GRP
PPH icon

Global Retirement Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

Global Retirement Partners’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.9K Buy
+319
New +$33K ﹤0.01% 2744
2025
Q4 		$19.9K Buy
193
+18
+10% +$1.75K ﹤0.01% 2871
2025
Q3 		$15.9K Sell
175
-95
-35% -$8.32K ﹤0.01% 2500
2025
Q2 		$23.8K Buy
+270
New +$23.4K ﹤0.01% 2200
2024
Q4 		$25.3K Sell
293
-167
-36% -$15.1K ﹤0.01% 1964
2024
Q3 		$43.7K Buy
460
+74
+19% +$7.03K ﹤0.01% 1618
2024
Q2 		$35.3K Sell
386
-5
-1% -$446 ﹤0.01% 1713
2024
Q1 		$35.4K Buy
391
+375
+2,344% +$32.8K ﹤0.01% 1557
2023
Q4 		$1.34K Buy
16
+1
+7% +$78 ﹤0.01% 2812
2023
Q3 		$1.2K Sell
15
-60
-80% -$4.84K ﹤0.01% 2716
2023
Q2 		$5.91K Hold
75
– – ﹤0.01% 2143
2023
Q1 		$5.95K Buy
+75
New +$5.78K ﹤0.01% 2108

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Global Retirement Partners's PPH Position: Q2 2026 in Review

Global Retirement Partners opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 319 shares worth $34.9K. The stake represents ﹤0.01% of the portfolio and ranks #2744 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PPH as recently as Q4 2025.

Global Retirement Partners first reported a position in PPH in Q1 2023 and has held it in 12 quarters since. The position peaked at $43.7K in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Global Retirement Partners held 319 shares of VanEck Pharmaceutical ETF worth $34.9K as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new Global Retirement Partners position in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2744 holding.
  • Global Retirement Partners first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and has held it in 12 quarters since.
  • Global Retirement Partners's VanEck Pharmaceutical ETF position peaked at $43.7K in Q3 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.